• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    AbbVie Inc. (ABBV)

    -NYSE
    66.59 Down 0.88(1.30%) May 29, 4:00PM EDT
    |After Hours : 66.80 Up 0.21 (0.31%) May 29, 7:57PM EDT
    Add to Portfolio
    Prev Close:67.47
    Open:67.22
    Bid:66.59 x 1000
    Ask:66.79 x 100
    1y Target Est:73.23
    Beta:1.63
    Earnings Date:Jul 23 - Jul 27 (Est.)
    Day's Range:66.39 - 67.51
    52wk Range:51.37 - 70.76
    Volume:9,450,954
    Avg Vol (3m):12,294,900
    Market Cap:105.94B
    P/E (ttm):59.46
    EPS (ttm):1.12
    Div & Yield:2.04 (3.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABBV

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 1.30%105.94B
    MRKUp 1.99%172.03B
    NVSDown 1.46%248.64B
    PFEUp 0.90%213.98B

    Key Statistics

    Forward P/E (1 yr):13.40
    P/S (ttm):5.26
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.24
    Quarterly EPS Est (Jun-15) :1.05
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback